Macquarie Group
BVS icon

Macquarie Group’s Bioventus BVS Stock Holding History

Macquarie Group’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,997
Closed -$52 – 1721
2024
Q4 		$52 Buy
+4,997
New +$59.1K ﹤0.01% 1639
2024
Q2 		– Sell
-1,809
Closed -$9 – 1932
2024
Q1 		$9 Buy
+1,809
New +$8.84K ﹤0.01% 1729

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Macquarie Group's BVS Position: Q1 2025 in Review

Macquarie Group sold out of Bioventus (BVS) in Q1 2025, closing a stake of 4,997 shares — an estimated $52 sold.

Macquarie Group first reported a position in BVS in Q1 2024 and held it in 2 quarters. The position peaked at $52 in Q4 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Macquarie Group reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Macquarie Group sold 4,997 Bioventus shares in Q1 2025, an estimated $52.
  • Macquarie Group first reported a position in Bioventus in Q1 2024 and held it in 2 quarters.
  • Macquarie Group's Bioventus position peaked at $52 in Q4 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Macquarie Group's 13F filing for Q1 2025, filed 15 May 2025.